Transient in utero knockout (TIUKO) of C-MYC affects late lung and intestinal development in the mouse

BMC Developmental Biology

Volumn 4, Issue , 2004, Pages

  Cohen, J Craig ^a   Scott, Donald ^a   Miller, James ^b   Zhang, Jianxuan ^b   Zhou, Pengbo ^b   Larson, Janet E ^c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN; COMPLEMENTARY DNA; MYC PROTEIN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; INTESTINE; INTESTINE VILLUS; INTRAUTERINE GROWTH RETARDATION; KNOCKOUT GENE; KNOCKOUT MOUSE; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG HYPOPLASIA; NONHUMAN; ONCOGENE C MYC; ORGANOGENESIS; PROTEIN TARGETING; THIRD TRIMESTER PREGNANCY; ADENOVIRIDAE; ADENOVIRUS INFECTION; ANIMAL; CELL LINE; EMBRYOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG; MOUSE; ONCOGENE MYC; PHYSIOLOGY; PRENATAL DEVELOPMENT; VIROLOGY;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CELL LINE; DNA, ANTISENSE; DNA, VIRAL; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TRANSFER TECHNIQUES; GENES, MYC; INTESTINES; LUNG; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-MYC; UBIQUITIN;

EID: 2642571942     PISSN: 1471213X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-213X-4-4     Document Type: Article

References (33)

1. Ryan KM, Birnie GD: Myc oncogenes: the enigmatic family. Biochem J 1996, 314 (Pt 3):713-721.
2. Grandori C, Cowley SM, James LP, Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699.
3. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002, 16(19):2530-2543.
4. Malynn BA, de Alboran IM, O'Hagan RC, Bronson R, Davidson L, DePinho RA, Alt FW: N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 2000, 14(11):1390-1399.
5. Shu W, Jiang YQ, Lu MM, Morrisey EE: Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002, 129(20):4831-4842.
6. Lickert H, Kispert A, Kutsch S, Kemler R: Expression patterns of Wnt genes in mouse gut development. Mech Dev 2001, 105(1-2):181-184.
7. Sekhon HS, Larson JE: In utero gene transfer into the pulmonary epithelium. Nat Med 1995, 1 (11):1201-1203.
8. Larson JE, Morrow SL, Happel L, Sharp JF, Cohen JC: Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997, 349(9052):619-620.
9. Morrow SL, Larson JE, Nelson S, Sekhon HS, Ren T, Cohen JC: Modification of development by the CFTR gene in utero. Mol Genet Metab 1998, 65(3):203-212.
10. Cohen JC, Morrow SL, Cork RJ, Delcarpio JB, Larson JE: Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model. Mol Genet Metab 1998, 64(2):108-118.
11. Larson JE, Morrow SL, Delcarpio JB, Bohm RP, Ratterree MS, Blanchard JL, Cohen JC: Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000, 2(6):631-639.
12. Larson JE, Delcarpio JB, Farberman MM, Morrow SL, Cohen JC: CFTR modulates lung secretory cell proliferation and differentiation. Am J Physiol Lung Cell Mol Physiol 2000, 279(2):L333-341.
13. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A: A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 1993, 7(4):671-682.
14. Collier JJ, Doan TT, Daniels MC, Schurr JR, Kolls JK, Scott DK: c-Myc is required for the glucose-mediated induction of metabolic enzyme genes. J Biol Chem 2003, 278(8):6588-6595.
15. Zhou P, Howley PM: Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol Cell 1998, 2(5):571-580.
16. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997, 45(11):1559-1565.
17. Kitano Y, von Allmen D, Kanai M, Adzick NS, Flake AW: Epinephrine inhibits tracheal occlusion induced lung growth in fetal sheep. Fetal Diagn Ther 2003, 18(5):333-337.
18. Deshaies RJ: SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol 1999, 15:435-467.
19. Willems AR, Lanker S, Patton EE, Craig KL, Nason TF, Mathias N, Kobayashi R, Wittenberg C, Tyers M: Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell 1996, 86(3):453-463.
20. Kipreos ET, Pagano M: The F-box protein family. Genome Biol 2000, 1(5):REVIEWS3002.
21. Winston JT, Koepp DM, Zhu C, Elledge SJ, Harper JW: A family of mammalian F-box proteins. Curr Biol 1999, 9(20):1180-1182.
22. Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R, Margottin-Goguet F: ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Mol Cell Biol 2001, 21(6):2192-2202.
23. Tan P, Fuchs SY, Chen A, Wu K, Gomez C, Ronai Z, Pan ZQ: Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell 1999, 3(4):527-533.
24. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW: The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 1999, 13(3):270-283.
25. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y: Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 1998, 396(6711):590-594.
26. Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin-Goguet F, Jackson PK, Yamasaki L, Pagano M: Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo. Dev Cell 2003, 4(6):799-812.
27. Margottin-Goguet F, Hsu JY, Loktev A, Hsieh HM, Reimann JD, Jackson PK: Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell 2003, 4(6):813-826.
28. Zhou P, Bogacki R, McReynolds L, Howley PM: Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. Mol Cell 2000, 6(3):751-756.
29. Zhang J, Zheng N, Zhou P: Exploring the functional complexity of cellular proteins by protein knockout. Proc Natl Acad Sci U S A 2003.
30. Cong F, Zhang J, Pao W, Zhou P, Varmus H: A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol 2003, 4(1):10.
31. Su Y, Ishikawa S, Kojima M, Liu B: Eradication of pathogenic beta-catenin by Skp1/Cullin/F box ubiquitination machinery. Proc Natl Acad Sci U S A 2003, 100(22):12729-12734.
32. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95(5):2509-2514.
33. Willert J, Epping M, Pollack JR, Brown PO, Nusse R: A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2002, 2(1):8.